Unlocking the Potential of BCDIN3D: A novel Domain-Containing Protein as a Drug Target or Biomarker

Target Name: BCDIN3D

NCBI ID: G144233

Other Name(s): BCDIN3 domain-containing protein | probable methyltransferase BCDIN3D | pre-miRNA 5'-monophosphate methyltransferase | RNA 5'-monophosphate methyltransferase | BCDIN3 domain containing RNA methyltrans

Unlocking the Potential of BCDIN3D: A novel Domain-Containing Protein as a Drug Target or Biomarker

Introduction

The protein domain-containing protein (PCP) is a class of proteins that possess unique structural features, primarily due to the arrangement of their amino acid residues. These features often provide the protein with distinct physical, chemical, and biological properties. BCDIN3D, a novel PCP, has recently been identified and is characterized for its unique domain structure and biological activity.

BCDI (尾-Catenin-Intein) is a family of proteins that are involved in various cellular processes, including cell adhesion, migration, and signaling. This family of proteins has been identified in various organisms, including humans. BCDIN3D is a member of the BCDIN3 family and is the first of its kind to be discovered.

The BCDIN3D protein is unique due to its structure domain, which consists of a 尾-catenin-like domain and a unique N-terminal region. The 尾-catenin-like domain is known for its ability to form a stable complex with the protein p120GAP , leading to the formation of the BCDIN3D-p120GAP complex. This complex plays a crucial role in regulating various cellular processes, including cell adhesion, migration, and signaling.

BCDI signaling is highly conserved across various organisms and has been implicated in various cellular processes, including cancer progression, neurodegeneration, and developmental disorders. BCDIN3D has been shown to be involved in the regulation of cell adhesion, migration, and the formation of neurotrophic contacts.

In addition to its potential role in neurodegeneration, BCDIN3D has also been shown to be a potential drug target. The BCDIN3D protein has been shown to be highly expressed in various tissues, including brain, spleen, and pancreas, making it an attractive target for small molecule inhibitors. Additionally, the BCDIN3D protein is also known to be involved in various signaling pathways, including the TGF-β pathway. This makes it a potential target for inhibitors that target this pathway.

BCDI signaling is also known to play a role in the regulation of cancer progression. Therefore, BCDIN3D may also be a potential biomarker for cancer diagnosis and treatment. The BCDIN3D protein has been shown to be involved in the regulation of cell adhesion, which is a critical step in cancer progression. Additionally, BCDIN3D has been shown to be involved in the regulation of neurotrophic factor (NTF) signaling, which is a critical factor in cancer progression.

Conclusion

In conclusion, BCDIN3D is a unique PCP that has been identified for its distinct domain structure and biological activity. The BCDIN3D protein is involved in various cellular processes, including cell adhesion, migration, and signaling. Its unique domain structure and its involvement in BDI signaling make it an attractive target for small molecule inhibitors. Additionally, BCDIN3D may also be a potential biomarker for cancer diagnosis and treatment. Further research is needed to fully understand the role of BCDIN3D in various cellular processes and its potential as a drug target or biomarker.

Protein Name: BCDIN3 Domain Containing RNA Methyltransferase

Functions: O-methyltransferase that specifically monomethylates 5'-monophosphate of cytoplasmic histidyl tRNA (tRNA(His)), acting as a capping enzyme by protecting tRNA(His) from cleavage by DICER1 (PubMed:28119416, PubMed:31329584, PubMed:31919512). Also able, with less efficiently, to methylate the 5' monophosphate of a subset of pre-miRNAs, acting as a negative regulator of miRNA processing (PubMed:23063121, PubMed:28119416). The 5' monophosphate of pre-miRNAs is recognized by DICER1 and is required for pre-miRNAs processing: methylation at this position reduces the processing of pre-miRNAs by DICER1 (PubMed:23063121). Was also reported to mediate dimethylation of pre-miR-145; however dimethylation cannot be reproduced by another group which observes a monomethylation of pre-miR-145 (PubMed:23063121, PubMed:28119416)

More Common Targets